{"version":"1","date_last_updated":"2019-09-04","submission_id":"500188.2014-08-28","interpretation_description":"Pathogenic","submission_names":[],"content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}}]}}","interpretation_comments":[],"submitter_id":"500188","clinical_assertion_trait_set_id":"SCV000188769","review_status":"no assertion criteria provided","trait_set_id":"3420","interpretation_date_last_evaluated":"2014-02-03","id":"SCV000188769","assertion_type":"variation to disease","record_status":"current","local_key":"NM_176795.3:c.173C\u003eT|MedGen:C0587248","internal_id":"335070","date_created":"2014-09-05","variation_id":"12610","variation_archive_id":"VCV000012610","clinical_assertion_observation_ids":["SCV000188769.0"],"rcv_accession_id":"RCV000013444"}
{"submitted_assembly":"GRCh37","version":"1","date_last_updated":"2019-09-11","submission_id":"25969.2018-10-10","interpretation_description":"Uncertain significance","submission_names":["SUB4618058"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","interpretation_comments":["{\"text\":\"One copy of the c.665C\u003eT; p.Ala222Val variant, also known as C677T or thermolabile variant, was detected in the MTHFR gene by massively parallel sequencing and confirmed by Sanger sequencing. This variant is observed in the general population at an overall allele frequency of 30.8% (85329/277132 alleles, including 15447 homozygotes) in the Genome Aggregation Database. This variant has been studied extensively and is considered a ''susceptibility'' or an ''association'' variant. The thermolabile c.665C\u003eT in a homozygous state has been correlated with reduced enzyme activity and increased homocysteine (Frosst 1995). Recent publication of the American College of Medical Genetics stated that this variant, c.665C\u003eT; p.Ala222Val, in the heterozygous form is unlikely to be of clinical significance (Hickey 2013); however, a possible effect of this variant when paired with the pathogenic MTHFR variant, on the opposite chromosome cannot be excluded. Deep intronic variants and variants in the untranslated region are not analyzed by this method; therefore, another pathogenic MTHFR variant cannot be ruled out.\"}"],"submitter_id":"25969","clinical_assertion_trait_set_id":"SCV000884146","review_status":"criteria provided, single submitter","trait_set_id":"9460","interpretation_date_last_evaluated":"2017-05-02","id":"SCV000884146","assertion_type":"variation to disease","record_status":"current","local_key":"74380|Not Provided","internal_id":"1730401","date_created":"2019-02-15","variation_id":"3520","variation_archive_id":"VCV000003520","clinical_assertion_observation_ids":["SCV000884146.0"],"rcv_accession_id":"RCV000153516"}
{"submitted_assembly":"GRCh37","version":"1","date_last_updated":"2019-09-04","submission_id":"505998.2017-08-18","interpretation_description":"Likely pathogenic","submission_names":["NIHR_Bioresource_Rare_Diseases_Retinal_Dystrophy"],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28041643\",\"@Source\":\"PubMed\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}}}}","interpretation_comments":[],"submitter_id":"505998","clinical_assertion_trait_set_id":"SCV000599010","review_status":"no assertion criteria provided","trait_set_id":"33742","interpretation_date_last_evaluated":"2015-01-01","id":"SCV000599010","assertion_type":"variation to disease","record_status":"current","local_key":"c.6148G\u003eC_HP:0000548","internal_id":"1160860","date_created":"2017-09-07","variation_id":"7884","variation_archive_id":"VCV000007884","clinical_assertion_observation_ids":["SCV000599010.0"],"rcv_accession_id":"RCV000504806"}
{"submitted_assembly":"GRCh37","version":"2","date_last_updated":"2019-09-11","submission_id":"25969.2018-10-10","interpretation_description":"Likely benign","submission_names":["SUB4618058"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","interpretation_comments":["{\"text\":\"The APC c.3920T\u003eA; p.Ile1307Lys variant has been reported extensively in the literature. One recent meta-analysis of 30 published population studies, all of which examined the association between p.Ile1307Lys and colorectal neoplasia, colorectal adenoma, and/or colorectal cancer, concluded that this variant confers a two-fold increased risk of developing a colorectal neoplasia to persons of Ashkenazi Jewish ancestry (Liang 2013 and references therein). However, the c.3920T\u003eA;p.Ile1307Lys variant is observed in the general population at an overall frequency of 0.18% (506/276756 alleles, 6 homozygotes) in the Genome Aggregation Database. Due to the high frequency in the general population, this variant is considered likely benign. REFERENCES Liang et al. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol. 2013;177(11):1169-1179.\"}"],"submitter_id":"25969","clinical_assertion_trait_set_id":"SCV000602533","review_status":"criteria provided, single submitter","trait_set_id":"9460","interpretation_date_last_evaluated":"2018-06-20","id":"SCV000602533","assertion_type":"variation to disease","record_status":"current","local_key":"11931|Not Provided","internal_id":"1166229","date_created":"2017-09-27","variation_id":"822","variation_archive_id":"VCV000000822","clinical_assertion_observation_ids":["SCV000602533.0"],"rcv_accession_id":"RCV000034388"}
{"version":"1","date_last_updated":"2019-09-10","submission_id":"1160.2012-07-15","interpretation_description":"variant of unknown significance","submission_names":["ClinSeq_cancer"],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},\"StudyName\":{\"$\":\"ClinSeq\"}}","interpretation_comments":["{\"text\":\"Converted during submission to Uncertain significance.\"}"],"submitter_id":"1160","clinical_assertion_trait_set_id":"SCV000043125","review_status":"no assertion criteria provided","trait_set_id":"9460","interpretation_date_last_evaluated":"2012-07-13","id":"SCV000043125","assertion_type":"variation to disease","record_status":"current","local_key":"NM_000038.4:c.3920T\u003eA|not provided","internal_id":"98286","date_created":"2013-03-26","variation_id":"822","variation_archive_id":"VCV000000822","clinical_assertion_observation_ids":["SCV000043125.0"],"rcv_accession_id":"RCV000034388"}
{"submitted_assembly":"GRCh37","version":"7","date_last_updated":"2019-09-28","submission_id":"26957.2019-01-29","interpretation_description":"Pathogenic","submission_names":["SUB5098196"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","interpretation_comments":["{\"text\":\"The c.2096_2100delGAAAG pathogenic variant in the JAG1 gene has been reported previously in two unrelated individuals with Alagille syndrome using alternate nomenclature c.2504del5 (Krantz et al., 1998). The c.2096_2100delGAAAG variant causes a frameshift starting with codon Glycine 699, changes this amino acid to an Aspartic Acid residue, and creates a premature Stop codon at position 6 of the new reading frame, denoted p.Gly699AspfsX6. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.2096_2100delGAAAG variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.2096_2100delGAAAG as a pathogenic variant.\",\"type\":\"public\"}"],"submitter_id":"26957","clinical_assertion_trait_set_id":"SCV000321788","review_status":"criteria provided, single submitter","trait_set_id":"9460","interpretation_date_last_evaluated":"2016-06-21","id":"SCV000321788","assertion_type":"variation to disease","record_status":"current","local_key":"GDX:27415|Not Provided","internal_id":"616441","date_created":"2016-10-07","variation_id":"7621","variation_archive_id":"VCV000007621","clinical_assertion_observation_ids":["SCV000321788.0"],"rcv_accession_id":"RCV000255046"}
{"submitted_assembly":"GRCh37","version":"1","date_last_updated":"2019-09-28","submission_id":"500031.2017-10-05","interpretation_description":"Pathogenic","submission_names":["SUB3109251"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","interpretation_comments":["{\"text\":\"This sequence change deletes 5 nucleotides from exon 16 of the JAG1 mRNA (c.2096_2100delGAAAG), causing a frameshift at codon 699. This creates a premature translational stop signal (p.Gly699Aspfs*6) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAG1 are known to be pathogenic. This particular variant has been reported in the literature in individuals affected with Alagille syndrome (PMID: 9585603). It is also called 2504del5 in the literature. For these reasons, this variant has been classified as Pathogenic.\",\"type\":\"public\"}"],"submitter_id":"500031","clinical_assertion_trait_set_id":"SCV000645524","review_status":"criteria provided, single submitter","trait_set_id":"2076","interpretation_date_last_evaluated":"2017-03-22","id":"SCV000645524","assertion_type":"variation to disease","record_status":"current","local_key":"1537816|MedGen:C1956125","internal_id":"1238063","date_created":"2017-12-20","variation_id":"7621","variation_archive_id":"VCV000007621","clinical_assertion_observation_ids":["SCV000645524.0"],"rcv_accession_id":"RCV000008060"}
{"submitted_assembly":"GRCh37","version":"2","date_last_updated":"2019-09-28","submission_id":"500060.2018-09-19","interpretation_description":"Pathogenic","submission_names":["SUB4534263"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=JAG1\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9585603\",\"@Source\":\"PubMed\"}}}}","interpretation_comments":[],"submitter_id":"500060","clinical_assertion_trait_set_id":"SCV000708478","review_status":"criteria provided, single submitter","trait_set_id":"9460","interpretation_date_last_evaluated":"2018-09-12","id":"SCV000708478","assertion_type":"variation to disease","record_status":"current","local_key":"62018_000000","internal_id":"1380875","date_created":"2018-03-28","variation_id":"7621","variation_archive_id":"VCV000007621","clinical_assertion_observation_ids":["SCV000708478.0"],"rcv_accession_id":"RCV000255046"}
{"submitted_assembly":"GRCh37","version":"2","date_last_updated":"2019-09-11","submission_id":"25969.2018-10-10","interpretation_description":"Pathogenic","submission_names":["SUB4618058"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant (rs375882485) is a well-known causative variant reported in multiple individuals with hypertrophic cardiomyopathy (HCM; Richard 2003, Maron 2008, Kaski 2012, and Lopez 2013), and shown to segregate with disease in at least one affected family (Camuglia 2013). In one large study, the p.Arg502Trp variant was identified in 2.4% of Caucasian HCM patients (Saltzman 2010). Nuclear magnetic resonance studies indicate that p.Arg502Trp may impair important electrostatic interactions between MYBPC3 protein and other sarcomeric proteins (Zhang 2014). Thus, the p.Arg502Trp variant meets our criteria for classification as pathogenic.\"}"],"submitter_id":"25969","clinical_assertion_trait_set_id":"SCV000604327","review_status":"criteria provided, single submitter","trait_set_id":"9460","interpretation_date_last_evaluated":"2017-06-22","id":"SCV000604327","assertion_type":"variation to disease","record_status":"current","local_key":"118047|Not Provided","internal_id":"1168023","date_created":"2017-09-27","variation_id":"42540","variation_archive_id":"VCV000042540","clinical_assertion_observation_ids":["SCV000604327.0"],"rcv_accession_id":"RCV000223898"}
{"submitted_assembly":"GRCh37","version":"2","date_last_updated":"2019-09-23","submission_id":"505530.2019-08-02","interpretation_description":"Pathogenic","submission_names":["SUB6121785"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"StudyName\":{\"$\":\"AGHI_GT\"}}","interpretation_comments":[],"submitter_id":"505530","clinical_assertion_trait_set_id":"SCV000803346","review_status":"criteria provided, single submitter","trait_set_id":"2365","interpretation_date_last_evaluated":"2018-12-10","id":"SCV000803346","assertion_type":"variation to disease","record_status":"current","local_key":"11:47364249:G","internal_id":"1566231","date_created":"2018-08-10","variation_id":"42540","variation_archive_id":"VCV000042540","clinical_assertion_observation_ids":["SCV000803346.0","SCV000803346.1","SCV000803346.2","SCV000803346.3"],"rcv_accession_id":"RCV000677196"}
